Loading...

Restructuring And AI Trials Will Advance Spinal Cord Stimulation

Published
03 Apr 25
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-56.1%
7D
0%

Author's Valuation

US$6.5310.6% undervalued intrinsic discount

AnalystConsensusTarget Fair Value